Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.
about
Precision medicine in NSCLC and pathology: how does ALK fit in the pathway?Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancerSensitive and affordable diagnostic assay for the quantitative detection of anaplastic lymphoma kinase (ALK) alterations in patients with non-small cell lung cancer.ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.The present state of the art in expression, production and characterization of monoclonal antibodies.Performance of a RT-PCR Assay in Comparison to FISH and Immunohistochemistry for the Detection of ALK in Non-Small Cell Lung Cancer.Profile of Ventana ALK (D5F3) companion diagnostic assay for non-small-cell lung carcinomas.ALK alterations and inhibition in lung cancer.Efficacy of crizotinib in first-line treatment of adults with ALK-positive advanced NSCLC.Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.ALK gene rearranged lung adenocarcinomas: molecular genetics and morphology in cohort of patients from North India.Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approachesImmunohistochemistry for predictive biomarkers in non-small cell lung cancer.Comparison of ALK status between primary and corresponding lymph node metastatic tumors in lung cancer patients.Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS.Anaplastic lymphoma kinase (ALK) mutations in patients with adenocarcinoma of the lung.The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking.A comparison of ALK gene rearrangement and ALK protein expression in primary lung carcinoma and matched metastasis.Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer.[Statement of the German Society for Pathology and the working group thoracic oncology of the working group oncology/German Cancer Society on ALK testing in NSCLC: Immunohistochemistry and/or FISH?].Anaplastic lymphoma kinase (ALK)-expressing Lung Adenocarcinoma with Combined Neuroendocrine Component or Neuroendocrine Transformation: Implications for Neuroendocrine Transformation and Response to ALK-tyrosine Kinase Inhibitors.Significance and evaluation of anaplastic lymphoma kinase by immunohistochemistry in non-small cell lung cancer.NSCLC molecular testing in Central and Eastern European countries.ALK (D5F3) CDx: an immunohistochemistry assay to identify ALK-positive NSCLC patients
P2860
Q26738390-57472E96-D1B2-4F62-9678-BA344620D740Q36096398-9CF19791-A415-4E79-B431-C95A0058105AQ37392933-C3BA841E-576C-4086-8461-3E6932A2FE1AQ37696243-3A457FBF-D67A-4EC0-9B4D-BBF41E14EE69Q38572163-C01C7CD1-FA30-4070-B51A-98D535256DFAQ38649524-F26B2771-D711-466E-806D-153814905561Q38794422-A1E8CA26-0610-4C20-A0D7-8524DBCC4117Q38820412-83F59CB9-759D-481C-862A-7E6F8E2AC898Q38846823-6D3CCD11-2525-496B-A391-B95BC5DAA053Q38995524-32D8DC1B-DEBE-4B50-ACAD-E73D47CDC4A8Q39512988-81E16A6F-EEC9-4097-B8C9-AB9D17B792D2Q42286165-491E9B7B-E40A-407E-9390-A839E2EB5AFFQ47140225-D5BED0C9-96D2-48C6-AC7D-26D4869158A6Q47220523-BE9D5F2A-F86C-4C5A-B70E-C0AFC79BE91BQ47578326-5D43DF10-E016-4D1C-BE0B-78721E8C8F41Q47699895-95DDCEE4-FA39-4905-A7D7-337648DC8FC8Q48021469-00D5298D-C137-4190-B9B2-2D14497BD5ECQ48108243-38481758-1E39-4954-9D83-3833445BE2BAQ48254761-397C241C-5048-44EE-B468-F2825DCF2165Q52854883-F1970931-1915-4EE0-B35B-2E613F9D49A5Q54116999-F5D5CB01-C92C-411C-A8CE-D6AF2711F201Q55030710-2DE38C88-1572-416D-AF41-30DC51C5B8C5Q55284375-44B94F0F-D98E-4A9B-89BB-CA8D5D6F5C8BQ57074582-0631BD50-62F9-481C-A239-B0B324A81758
P2860
Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Screening for ALK in non-small ...... use with FISH is recommended.
@en
type
label
Screening for ALK in non-small ...... use with FISH is recommended.
@en
prefLabel
Screening for ALK in non-small ...... use with FISH is recommended.
@en
P2093
P1433
P1476
Screening for ALK in non-small ...... use with FISH is recommended.
@en
P2093
Anne-Katrin Zimmermann
Betty Baschiera
Joachim Diebold
Keith Kerr
Lukas Bubendorf
Spasenija Savic
Susanne Grieshaber
Wolfram Jochum
P304
P356
10.1016/J.LUNGCAN.2015.05.012
P577
2015-05-21T00:00:00Z